XT
VRAX icon

XTX Topco’s Virax Biolabs VRAX Stock Holding History

XTX Topco’s Portfolio VRAX Stock Details VRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-857
Closed -$7.41K – 4439
2025
Q4 		$7.41K Buy
+857
New +$10.9K ﹤0.01% 3217
2025
Q1 		– Sell
-475
Closed -$26.7K – 3175
2024
Q4 		$26.7K Buy
+475
New +$22.7K ﹤0.01% 2000

Other funds holding VRAX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

XTX Topco's VRAX Position: Q1 2026 in Review

XTX Topco sold out of Virax Biolabs (VRAX) in Q1 2026, closing a stake of 857 shares — an estimated $7.41K sold.

XTX Topco first reported a position in VRAX in Q4 2024 and held it in 2 quarters. The position peaked at $26.7K in Q4 2024. 4 funds tracked by Wall St. Rank hold VRAX as of Q1 2026.

  • XTX Topco reported no remaining Virax Biolabs position as of Q1 2026 after selling out during the quarter.
  • XTX Topco sold 857 Virax Biolabs shares in Q1 2026, an estimated $7.41K.
  • XTX Topco first reported a position in Virax Biolabs in Q4 2024 and held it in 2 quarters.
  • XTX Topco's Virax Biolabs position peaked at $26.7K in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Virax Biolabs as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.